Featuring an interview with Dr Heather Wakelee, including the following topics:
- Similarities and differences in the efficacy of neoadjuvant and adjuvant immunotherapies for localized non-small cell lung cancer (NSCLC) (0:00)
- Available data on the treatment of patients whose disease relapses on or after adjuvant immunotherapy (6:15)
- Activity of immunotherapy in patients whose tumors are EGFR mutated (10:29)
- Case: A woman in her mid 70s with EGFR-mutated NSCLC in her right lung (14:49)
- Case: A woman in her early 60s with a smoking history and a 4-cm right lower lobe lesion (24:17)
- Case: A man in his mid 50s with a smoking history and a left upper lobe mass with high PD-L1 expression (28:04)
- Optimal treatment of localized NSCLC in patients who have alterations in RET, BRAF and ALK (33:08)
- Importance of primary care doctors screening their patients for lung cancer (37:03)
CME information and select publications
Research To Practice | Oncology Videos